Category: Health Care Quality

The VA Scandal and Cheap Government Medicine

The VA waiting list scandal is a strong piece of evidence that governments running monopoly health systems have few incentives to provide quality health care. The easiest way to cut costs is to deny access to prompt care, advanced treatments, and new drugs. As far back as 2007, the VA Inspector General reported that some of its facilities keep poor records and had long waits for care. It has never accurately estimated the size of its waiting lists, or been able to say exactly how it spends its budget.

VA care looks better than it is because a lot of veterans have Medicare or other private insurance. They can switch to private care when the VA fails. And VA care does fail. Even if they make it to the top of the waiting list, people stuck in the VA are 35 percent less likely to receive kidney transplants or effective modern drugs than people with private insurance.

Like most government entities, the VA often seems more concerned about the people who work for it than the patients it is supposed to serve. In 1995, he GAO reported that the VA shields “its physicians from the professional accountability that is required of private sector practitioners,” and it is not clear whether all of its hospitals have formal processes to report incidences of serious injury, death, or potential legal liability. In 2003, its electronic records were found to contain numerous errors, and did not include some important adverse events. As of 2007, its electronic patient records could be edited by unauthorized people.

Read More » »

Quiz of the Day: Define Overtreatment

Now that government is paying the health care bills we are hearing a lot about overtreatment. As always, where one stands on it depends upon how one defines it.

Here is what the National Cancer Institute says about mammograms and overtreatment:

Screening mammograms can find cancers and cases of ductal carcinoma in situ (DCIS, a noninvasive tumor in which abnormal cells that may become cancerous build up in the lining of breast ducts) that need to be treated. However, they can also find cancers and cases of DCIS that will never cause symptoms or threaten a woman’s life, leading to “overdiagnosis” of breast cancer. Treatment of these latter cancers and cases of DCIS is not needed and leads to “overtreatment.” Overtreatment exposes women unnecessarily to the adverse effects associated with cancer therapy

Why not leave the harmless DCIS tumors alone?

Read More » »

Oops! Paul Krugman, Uwe Reinhardt, Nicholas Kristof, RAND Corporation All Praised the Veterans Health Administration

Ben Shapiro (Truth Revolt) has posted a list of recent quotations from leading public intellectuals cheerleading the VHA as a model of a well-functioning health system. Here’s former Enron adviser Paul Krugman in 2011:

Multiple surveys have found the VHA providing better care than most Americans receive, even as the agency has held cost increases well below those facing Medicare and private insurers…the VHA is an integrated system, which provides health care as well as paying for it. So it’s free from the perverse incentives created when doctors and hospitals profit from expensive tests and procedures, whether or not those procedures actually make medical sense.

Should Taxpayers Spend $250,000 to Give an Uninsured Person 16 Days of Healthy Life?

ObamaCare spends a lot of money that could be better spent elsewhere:

money-crossroadsSo, even when we combine the most optimistic estimates of gains in mortality and morbidity, the average uninsured person would gain about 16 healthy days a year…As a comparison, 75-year-olds with foot problems prior to chiropody treatment rate their quality of life at .956. For the average uninsured person, having health insurance coverage provides health benefits that are roughly equivalent to averting the foot problems experienced by typical 75-year-olds.

More importantly, even using the most optimistic assumptions, ObamaCare does not appear to be very cost-effective in relative terms. That is, we could attain the equivalent gains in health status for only 4% of the trillions that will be spent on ObamaCare. Conversely, for the same massive expenditure, we could attain up to 27 times as much improvement in health status. In light of this rather egregious squandering of other people’s money, it’s little surprise that opposition to ObamaCare has been so persistent and widespread.

From: Christopher Conover at Forbes.

Canadian Health Care’s War on Women: Waiting for Treatment Increases Female Deaths

UntitledCanada’s growing wait times for health care may have contributed to the deaths of 44,273 Canadian women between 1993 and 2009…The estimated 44,273 deaths between 1993 and 2009 represent 2.5 percent of all female deaths in Canada during that 16-year period, or 1.2 percent of Canada’s total mortality (male and female).

More specifically, during that same 16-year period, for every one-week increase in the post-referral wait time for medically necessary elective procedures, three female Canadians died (per 100,000 women).

No significant relationship between wait times and male mortality rates was found.

Source: Fraser Institute.

VA Secret Waiting Time Cover-Up is Snowballing

people-in-waiting-roomThe number of VA facilities under investigation after complaints about falsified records and treatment delays has more than doubled in recent days, the Office of Inspector General at the Veterans Affairs Department said late Tuesday.

A spokeswoman for the IG’s office said 26 facilities were being investigated nationwide. Acting Inspector General Richard Griffin told a Senate committee last week that at least 10 new allegations about manipulated waiting times and other problems had surfaced since reports of problems at the Phoenix VA hospital came to light last month.

(AP via Christian Science Monitor)

Government Handouts for Electronic Health Records: Standards Lowered to Ensure Money Keeps Flowing

We recently noted that, halfway through the year, only four hospitals and 50 physicians have achieved the federal government’s goals for “meaningful use” of electronic health records (EHRS). The federal government has a goal of spending $30 billion to induce hospitals and physicians to adopt EHRs, and it still has about $8 billion to spend. In order to ensure the money keeps flowing, standards have been lowered:

The new rule, released May 20 and slated to be published in the Federal Register May 23, would enable providers to use the 2011 edition of certified electronic health record technology for Stage 1 or Stage 2 in 2014. They would have the option to attest to the 2013 definition of Meaningful Use core and menu items and use the 2013 definition of clinical quality measures. (FierceHealth EMR)

So, hospitals and physician practices which received handouts in previous years are pretty much guaranteed to receive a handout this year, just by resubmitting the old paperwork.

Some New Medicines are Approved More Quickly than Others

Joe DiMasi of the Tufts Center for the Study of Drug Development, and colleagues, have reviewed the time it takes for the FDA to review different types of new drugs.

seniors-and-prescriptionsFDA’s Neurology division, which approves drugs for Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and stroke, takes three times as long to approve drugs as the Oncology division. These differences cannot be explained by differences workload, the type and complexity of the drugs reviewed, or the safety of the drugs approved.

If the FDA could cut the performance gap between the divisions in half, the authors estimate that the cost of developing a new drug would decrease by $46 million — a savings that adds up to approximately $874 million per year.

Full report available from the Manhattan Institute.

Patient “Activation” in the Spin Cycle — Professors, Scams, and Conflicts of Interest

7567567

(Fowles, et al. Journal of Patient Education and Counseling, 2009)

If you “strongly agree” with most of the questions above, you are a “highly activated,” patient. According to an article in the Wall Street Journal, health researchers have determined that the Patient Activation Measure (PAM) can identify “highly activated” patients, and that “highly activated patients” have better outcomes. (A New Vital Sign to Gauge: The Patient’s “Activation” Level, p. D1).

Judith Hibbard, identified as lead developer of the PAM assessment and a senior researcher at the University of Oregon’s Health Policy Research Group, assured the article’s author that the PAM is more than just a non-stick cooking spray: “Everyone assumes this is sort of a soft science, but we can measure patient activation just as rigorously and scientifically as other things in health care,” she reportedly said.

If that’s the case, health care is in bad shape.

Read More » »

Advances in Personalized Medicine

An article published Thursday in the journal Science describes the treatment of a 43-year-old woman with an advanced and deadly type of cancer that had spread from her bile duct to her liver and lungs, despite chemotherapy.

Researchers at the National Cancer Institute sequenced the genome of her cancer and identified cells from her immune system that attacked a specific mutation in the malignant cells. Then they grew those immune cells in the laboratory and infused billions of them back into her bloodstream.

The tumors began “melting away,” said Dr. Steven A. Rosenberg, the senior author of the article and chief of the surgery branch at the cancer institute.

…[T]he report is noteworthy because it describes an approach that may also be applied to common tumors — like those in the digestive tract, ovaries, pancreas, lungs and breasts — that cause more than 80 percent of the 580,000 cancer deaths in the United States every year. (New York Times)

See our previous posts here and here.